XIAP and urinary bladder cancer: Another previous study by our research group demonstrated that the combined knockdown of Livin, XIAP and Survivin in bladder cancer cell lines could remove the barricade in the apoptotic pathway more effectively than when only a single gene was suppressed, which may suggest a potent multitargeted gene therapy for bladder cancer (17).